JP2017500030A5 - - Google Patents

Download PDF

Info

Publication number
JP2017500030A5
JP2017500030A5 JP2016538531A JP2016538531A JP2017500030A5 JP 2017500030 A5 JP2017500030 A5 JP 2017500030A5 JP 2016538531 A JP2016538531 A JP 2016538531A JP 2016538531 A JP2016538531 A JP 2016538531A JP 2017500030 A5 JP2017500030 A5 JP 2017500030A5
Authority
JP
Japan
Prior art keywords
acid sequence
seq
set forth
nucleic acid
sequence set
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016538531A
Other languages
English (en)
Japanese (ja)
Other versions
JP7078350B2 (ja
JP2017500030A (ja
Filing date
Publication date
Priority claimed from PCT/US2013/075137 external-priority patent/WO2014093894A2/en
Application filed filed Critical
Priority claimed from PCT/US2014/070188 external-priority patent/WO2015089492A2/en
Publication of JP2017500030A publication Critical patent/JP2017500030A/ja
Publication of JP2017500030A5 publication Critical patent/JP2017500030A5/ja
Priority to JP2021108614A priority Critical patent/JP2021166534A/ja
Application granted granted Critical
Publication of JP7078350B2 publication Critical patent/JP7078350B2/ja
Priority to JP2023108341A priority patent/JP2023138998A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016538531A 2012-12-13 2014-12-13 Dna抗体構築物及びその使用方法 Active JP7078350B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2021108614A JP2021166534A (ja) 2013-12-13 2021-06-30 Dna抗体構築物及びその使用方法
JP2023108341A JP2023138998A (ja) 2012-12-13 2023-06-30 Dna抗体構築物及びその使用方法

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201361896646P 2013-10-28 2013-10-28
USPCT/US2013/075137 2013-12-13
PCT/US2013/075137 WO2014093894A2 (en) 2012-12-13 2013-12-13 Dna antibody constructs and method of using same
PCT/US2014/070188 WO2015089492A2 (en) 2013-12-13 2014-12-13 Dna antibody constructs and method of using same

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2020035240A Division JP2020108381A (ja) 2012-12-13 2020-03-02 Dna抗体構築物及びその使用方法
JP2021108614A Division JP2021166534A (ja) 2012-12-13 2021-06-30 Dna抗体構築物及びその使用方法

Publications (3)

Publication Number Publication Date
JP2017500030A JP2017500030A (ja) 2017-01-05
JP2017500030A5 true JP2017500030A5 (enrdf_load_stackoverflow) 2018-01-25
JP7078350B2 JP7078350B2 (ja) 2022-05-31

Family

ID=81845563

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016538531A Active JP7078350B2 (ja) 2012-12-13 2014-12-13 Dna抗体構築物及びその使用方法

Country Status (1)

Country Link
JP (1) JP7078350B2 (enrdf_load_stackoverflow)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112015013700A8 (pt) * 2012-12-13 2020-02-18 Inovio Pharmaceuticals Inc composição, sequência nucleotídica, anticorpo sintético, e, uso da composição
GB201704417D0 (en) * 2017-03-20 2017-05-03 Univ Copenhagen Improved li vaccine adjuvant

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2526120A1 (en) 2003-06-03 2005-02-24 Cell Genesys, Inc. Compositions and methods for enhanced expression of recombinant polypeptides from a single vector using a peptide cleavage site
US7714119B2 (en) * 2004-07-13 2010-05-11 Biosante Pharmaceuticals, Inc. AAV vector compositions and methods for enhanced expression of immunoglobulins using the same
JP5814790B2 (ja) 2008-10-13 2015-11-17 インスティテュート・フォー・リサーチ・イン・バイオメディシンInstitute For Research In Biomedicine デングウイルス中和抗体およびその使用

Similar Documents

Publication Publication Date Title
UA124343C2 (uk) Капсиди аденоасоційованого вірусу і спосіб його використання
MX2018010824A (es) Proteinas de union inducibles y metodos de uso.
EA201792573A1 (ru) Триспецифические связанные белки и способы их применения
WO2015188132A8 (en) Methods of constructing amino terminal immunoglobulin fusion proteins and compositions thereof
JP2016529229A5 (enrdf_load_stackoverflow)
JP2016053091A5 (enrdf_load_stackoverflow)
RU2017134456A (ru) Рекомбинантные связывающие белки и их применение
CR20230026A (es) Proteínas de fusión gdf15 y usos de estas (divisional 2018-0532)
IL288541B (en) Vaccine against rsv
JP2013107899A5 (enrdf_load_stackoverflow)
JP2015212284A5 (enrdf_load_stackoverflow)
EA201491049A1 (ru) Противораковый слитый белок
JP2016501535A5 (enrdf_load_stackoverflow)
EA201200515A1 (ru) Полипептиды и их применение
BR112015020315A2 (pt) conjugação de anticorpo-fármaco sítio-específica por glicoengenharia
JP2017537621A5 (enrdf_load_stackoverflow)
RU2017114673A (ru) Слитый белок, наночастица, состоящая из множества мономеров указанного слитого белка, и их применение
EA201990885A1 (ru) Композиции, содержащие короткие пептиды, полученные из pedf, и их применение
JP2014510519A5 (enrdf_load_stackoverflow)
PL393578A1 (pl) Przeciwnowotworowe białko fuzyjne
PE20181956A1 (es) Polipeptidos que inhiben cd40l
RU2017132689A (ru) СЛИТАЯ С Fc α-ЦЕПЬ ВЫСОКОАФФИННОГО РЕЦЕПТОРА IgE
NZ769391A (en) Serpin fusion polypeptides and methods of use thereof
EA201790341A1 (ru) Анти-ск8 антитела для применения в лечении рака
JP2016520534A5 (enrdf_load_stackoverflow)